Intera Oncology has a serious infusion pump recall

[Image from Intera Oncology’s webiste]The FDA issued a notice today declaring that the recall of an infusion pump from Intera Oncology is Class I, the most serious kind.

Intera recalled the Intera 3000 hepatic artery infusion pump after receiving reports from clinicians that the pumps were delivering medications (flow rate) faster than expected. If the pump delivers infusions at faster than expected flow rates, the patient may receive too much medication at one time, resulting in life-threatening hematologic (myelosuppression) toxicity, neurotoxicity or death.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0